Because of a lapse in government funding, the information on this
website may not be up to date, transactions submitted via the
website may not be processed, and the agency may not be able to
respond to inquiries until appropriations are enacted. The NIH
Clinical Center (the research hospital of NIH) is open. For more
details about its operating status, please visit
cc.nih.gov. Updates
regarding government operating status and resumption of normal
operations can be found at
opm.gov.
specialty; prefer specific drug or toxic substance and specific genetic aspect
Scope Note
The study of existing genetic knowledge, and the generation of new genetic data, to understand and thus avoid DRUG TOXICITY and adverse effects from toxic substances from the environment.
Entry Term(s)
Toxicogenomics
NLM Classification #
QV 38.5
Previous Indexing
Pharmacogenetics (1993-2003)
Toxicology (1993-2003)
Public MeSH Note
2004; see PHARMACOGENETICS 2003; for TOXICOGENOMICS see PHARMACOGENETICS 2003
History Note
2004; use PHARMACOGENETICS 2003; for TOXICOGENOMICS use PHARMACOGENETICS 2003
The study of existing genetic knowledge, and the generation of new genetic data, to understand and thus avoid DRUG TOXICITY and adverse effects from toxic substances from the environment.
The collection, interpretation and storage of information about gene and protein activity in order to identify toxic substances in the environment and those populations at greatest risk to environmental diseases.